Investing.com - Biofrontera ADR reported on Tuesday first quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Biofrontera ADR announced earnings per share of $-0.255 on revenue of $6.64M. Analysts polled by Investing.com anticipated EPS of $-0.22 on revenue of $6.6M.
Biofrontera ADR shares are down 13.19% from the beginning of the year and are trading at $5.74 , down-from-52-week-high.They are under-performing the Nikkei 225 which is up 2.56% from the start of the year.
Biofrontera ADR follows other major sector earnings this month
Biofrontera ADR's report follows an earnings beat by Industrial Commercial Bank of China on Thursday, April 29, 2021, who reported EPS of $0.7417 on revenue of $33.09B, compared to forecasts EPS of $0.6343 on revenue of $34.72B.
L’Oreal ADR had matched expectations on Thursday, April 15, 2021 with first quarter EPS of $1.03 on revenue of $9.12B, compared to forecast for EPS of $1.03 on revenue of $9.23B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar